共 50 条
- [1] Validation of a Sampling Method to Collect Exposure Data for Central-Line-Associated Bloodstream Infections [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (05): : 549 - 554
- [3] Central-line-associated bloodstream infections and central-line-associated non-CLABSI complications among pediatric oncology patients [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (03): : 377 - 383
- [4] Perspectives on central-line-associated bloodstream infection surveillance in home infusion therapy [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2019, 40 (06): : 729 - 731
- [5] A comparison of National Healthcare Safety Network surveillance definitions to physician review for central-line-associated bloodstream infections [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (12): : 2062 - 2064
- [6] Central-line-associated bloodstream infections secondary to anaerobes: Time for a definition change? [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (10): : 1697 - 1698
- [7] Reduction of Central-Line-Associated Bloodstream Infections in a Spinal Cord Injury Unit [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S370 - S370
- [9] Impact of Expansion of Vascular Access Team on Central-line-Associated Bloodstream Infections [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S260 - S260
- [10] Accuracy of the NHSN Central-Line-Associated Bloodstream Infections (CLABSIs) Definition: The Experience of Two Geographically Proximal Hospitals [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S457 - S458